Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)
NCT02608346
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Women With BRCA1 Germline Deleterious Mutation
Interventions
PROCEDURE:
Blood sampling
Sponsor
Institut Curie